Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
Fizazi, Karim
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr 2009 - 1564-71 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1527-7755
10.1200/JCO.2008.19.2146 doi
Aged
Antibodies, Monoclonal--pharmacokinetics
Antibodies, Monoclonal, Humanized
Bone Density Conservation Agents--therapeutic use
Bone Neoplasms--complications
Bone Resorption--chemically induced
Breast Neoplasms--pathology
Collagen Type I--urine
Denosumab
Diphosphonates--administration & dosage
Female
Humans
Male
Middle Aged
Multiple Myeloma--pathology
Peptides--urine
Prostatic Neoplasms--pathology
RANK Ligand--antagonists & inhibitors
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr 2009 - 1564-71 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1527-7755
10.1200/JCO.2008.19.2146 doi
Aged
Antibodies, Monoclonal--pharmacokinetics
Antibodies, Monoclonal, Humanized
Bone Density Conservation Agents--therapeutic use
Bone Neoplasms--complications
Bone Resorption--chemically induced
Breast Neoplasms--pathology
Collagen Type I--urine
Denosumab
Diphosphonates--administration & dosage
Female
Humans
Male
Middle Aged
Multiple Myeloma--pathology
Peptides--urine
Prostatic Neoplasms--pathology
RANK Ligand--antagonists & inhibitors